research use only

Vindesine sulfate Microtubule Associated inhibitor

Cat.No.S2440

Vindesine sulfate, a vinca alkaloid derived from Catharanthus roseus, is a potent inhibitor of mitosis with antineoplastic activities. Vindesine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death.
Jump to

Quality Control

Batch: Purity: 98.60%
98.60

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (117.37 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 100 mg/mL

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 852 Formula

C43H57N5O11S

Storage (From the date of receipt)
CAS No. 59917-39-4 -- Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-05-06)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04043494 RECRUITING
Lymphoblastic Lymphoma, Childhood
University Hospital Muenster
2019-08-23 PHASE3
NCT07159620 RECRUITING
Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
2025-09-01 PHASE2
NCT03643276 RECRUITING
Acute Lymphoblastic Leukemia, Pediatric
Martin Schrappe
2018-07-15 PHASE3
NCT06918015 NOT_YET_RECRUITING
BTK Inhibitors; Follicular Lymphoma; Immunochemotherapy
Zhejiang Cancer Hospital
2025-05-01 PHASE2
NCT03206671 ACTIVE_NOT_RECRUITING
Mature B-cell Non-Hodgkin Lymphoma
University Hospital Muenster
2017-08-03 PHASE3
NCT07004075 NOT_YET_RECRUITING
Low-grade Glioma; Pediatric Low-grade Gliomas; pLGG With BRAF Alteration
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
2025-06-30 PHASE3

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map